These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16966487)

  • 1. Mast cells are required for normal healing of skin wounds in mice.
    Weller K; Foitzik K; Paus R; Syska W; Maurer M
    FASEB J; 2006 Nov; 20(13):2366-8. PubMed ID: 16966487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent.
    Siebenhaar F; Syska W; Weller K; Magerl M; Zuberbier T; Metz M; Maurer M
    Am J Pathol; 2007 Jun; 170(6):1910-6. PubMed ID: 17525259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin mast cells control T cell-dependent host defense in Leishmania major infections.
    Maurer M; Lopez Kostka S; Siebenhaar F; Moelle K; Metz M; Knop J; von Stebut E
    FASEB J; 2006 Dec; 20(14):2460-7. PubMed ID: 17142795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mast cells in atrial natriuretic peptide-induced cutaneous inflammation.
    Chai OH; Han EH; Choi YH; Kim SH; Kim HT; Galli SJ; Song CH
    Regul Pept; 2011 Feb; 167(1):79-85. PubMed ID: 21130119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin.
    Metz M; Botchkarev VA; Botchkareva NV; Welker P; Tobin DJ; Knop J; Maurer M; Paus R
    Exp Dermatol; 2004 May; 13(5):273-81. PubMed ID: 15140017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice.
    Shiota N; Nishikori Y; Kakizoe E; Shimoura K; Niibayashi T; Shimbori C; Tanaka T; Okunishi H
    Int Arch Allergy Immunol; 2010; 151(1):80-8. PubMed ID: 19672099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation.
    Shao Z; Nazari M; Guo L; Li SH; Sun J; Liu SM; Yuan HP; Weisel RD; Li RK
    J Cell Mol Med; 2015 Dec; 19(12):2751-62. PubMed ID: 26471858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.
    Hochegger K; Siebenhaar F; Vielhauer V; Heininger D; Mayadas TN; Mayer G; Maurer M; Rosenkranz AR
    Eur J Immunol; 2005 Oct; 35(10):3074-82. PubMed ID: 16180252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo.
    Trautmann A; Toksoy A; Engelhardt E; Bröcker EB; Gillitzer R
    J Pathol; 2000 Jan; 190(1):100-6. PubMed ID: 10640999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell reactivity at the margin of human skin wounds: an early cell marker of wound survival?
    Oehmichen M; Gronki T; Meissner C; Anlauf M; Schwark T
    Forensic Sci Int; 2009 Oct; 191(1-3):1-5. PubMed ID: 19560296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
    Rigoni A; Bongiovanni L; Burocchi A; Sangaletti S; Danelli L; Guarnotta C; Lewis A; Rizzo A; Silver AR; Tripodo C; Colombo MP
    Cancer Res; 2015 Sep; 75(18):3760-70. PubMed ID: 26206557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.
    Kneilling M; Hültner L; Pichler BJ; Mailhammer R; Morawietz L; Solomon S; Eichner M; Sabatino J; Biedermann T; Krenn V; Weber WA; Illges H; Haubner R; Röcken M
    Arthritis Rheum; 2007 Jun; 56(6):1806-16. PubMed ID: 17530709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model.
    Siebenhaar F; Metz M; Maurer M
    Exp Dermatol; 2014 Mar; 23(3):159-64. PubMed ID: 24444017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
    Huttunen M; Naukkarinen A; Horsmanheimo M; Harvima IT
    Arch Dermatol Res; 2002 Oct; 294(7):324-30. PubMed ID: 12373338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.
    D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ
    J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin wounds.
    Zoog SJ; Itano A; Trueblood E; Pacheco E; Zhou L; Zhang X; Ferbas J; Ng GY; Juan G
    Cytometry A; 2009 Mar; 75(3):189-98. PubMed ID: 18937342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis.
    Sayed BA; Walker ME; Brown MA
    J Immunol; 2011 Mar; 186(6):3294-8. PubMed ID: 21325623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of mast cells does not enhance the impaired survival of Kit(W)/Kit(W-v) mice in a model of low dose intraperitoneal infection with bioluminescent Salmonella typhimurium.
    Chatterjea D; Burns-Guydish SM; Sciuto TE; Dvorak A; Contag CH; Galli SJ
    Immunol Lett; 2005 Jun; 99(1):122-9. PubMed ID: 15894120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.